The objective of the MIT CBI BioMANufacturing Research Program is to develop new knowledge, science, technologies and strategies that advance the manufacture and global delivery of high quality biopharmaceuticals. Bioman leverages MIT research in both engineering and science to advance new technologies for bioprocessing from high throughput platforms for speeding clonal selection and validated micro-bioreactors to novel sensors and new formulations
|
|
|
|
|
1-10 employees
View all Biomedical Innovation employees
|
|
|
Medical Practices
|
|
|
Cambridge, MA
|
|
|
Unkn
|
The decision makers in Biomedical Innovation are Elliott Antman, Elliott Antman, Erin Mckenna, etc. Click to Find Biomedical Innovation decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.